OncoCyte Corporation Profile Avatar - Palmy Investing

OncoCyte Corporation

OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test fo…

Biotechnology
US, Irvine [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

OncoCyte Corporation mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of OCX's Analysis
CIK: 1642380 CUSIP: 68235C107 ISIN: US68235C2061 LEI: - UEI: -
Secondary Listings
OCX has no secondary listings inside our databases.